UNSPSC 41181542: Immunoglobulin (light chain specific) immunological test system

In this classification, a Immunoglobulin (light chain specific) immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Immunoglobulin (light chain specific). US FDA regulates Immunoglobulin (light chain specific) immunological test system under 21 CFR 866.5550 and under FDA product code DAO.

UNSPSC 41181542 Immunoglobulin (light chain specific) immunological test system is a Commodity code that shows no recent state and local procurement activity aligned with its nominal scope. The recent opportunities posted under this code span optical surface profilometry, airfield photometric testing, drug discovery software licensing, electric meter test boards, high-voltage capacitance measurement modules, sterilization equipment maintenance, atmospheric gas monitoring, brake testing systems, laboratory testing and phlebotomy services, transformer oil analysis, spectrophotometry, and landscape architectural services. None of these solicitations involve immunoglobulin testing systems, immunological assays, or diagnostic serology platforms; the code appears to have been applied inconsistently or in error across unrelated procurements by colleges, utility authorities, state health agencies, cities, and counties in Florida, Texas, Colorado, Oregon, and other jurisdictions.

The mismatch between the code's definition and the actual goods and services being procured under it suggests that state and local buyers are either misclassifying these opportunities at the UNSPSC commodity level or that the code itself is being used as a default catch-all for specialized laboratory and testing equipment outside its intended domain. For firms pursuing contracts in clinical diagnostics, serology, or immunological testing platforms, this code does not reliably signal relevant procurement activity. Pursuing opportunities under this code would require direct verification against actual RFP or IFB language to confirm alignment with immunoglobulin-based test systems rather than relying on the code tag alone.